ResMed
Business Model Analysis
How ResMed Makes Money
Annual Revenue: $4.7B
- How does ResMed make money?
- ResMed makes money from Sleep and Respiratory Care Devices, Masks and Other Consumables and Residential Care / SaaS Software.
ResMed generates revenue primarily through Medical Devices & Digital Health, with roughly $4.7B in annual revenue.
Core Growth Engine: Under CEO Mick Farrell, ResMed is pursuing four key strategic growth drivers: (1) Expanding the Global Sleep Apnea Funnel: With an estimated 936 million people worldwide suffering from sleep apnea and over 80% remaining ...
Revenue Model & Pricing
ResMed operates a highly lucrative, resilient razor-and-blade medtech business model reinforced by high-margin software subscriptions: (1) Connected Devices (~53% of revenue / ~$2.5B), manufacturing premium CPAP, APAP, and bilevel flow generators (AirSense 11, AirCurve 11, AirMini) sold to home medical equipment (HME) suppliers and healthcare systems; (2) Masks & Consumables (~35% of revenue / ~$1.6B), delivering high-margin recurring cash flows from nasal, full-face, and minimalist nasal pillow masks (AirFit F30i, N30i, P10), silicone cushions, headgear, and humidification tubing that patients replace every 3 to 6 months; and (3) Out-of-Hospital SaaS Solutions (~12% of revenue / ~$560M), monetizing cloud subscription platforms including Brightree (HME billing and practice management), MatrixCare (long-term post-acute EHR), and MEDIFOX DAN (European ambulatory care software). ResMed generates gross margins near 59% and over $1.3 billion in annual operating cash flow.
Core Revenue Streams
Sleep and Respiratory Care Devices
52.2%Cloud-connected flow generators, continuous positive airway pressure (CPAP), and bi-level positive airway pressure (BiPAP) devices including the flagship AirSense 11, AirSense 10, AirCurve, Astral, and Stellar systems for sleep apnea and COPD.
Masks and Other Consumables
35.4%High-margin recurring patient interface consumables including AirFit and AirTouch nasal, full-face, and nasal pillow masks, replacement silicone and memory foam cushions, tubing, and air filtration accessories.
Residential Care / SaaS Software
12.4%Comprehensive out-of-hospital cloud-based healthcare software suites including Brightree for home medical equipment (HME) and pharmacy providers, MatrixCare for long-term post-acute care (LTPAC), and MEDIFOX DAN for outpatient care.
Growth Strategy
Under CEO Mick Farrell, ResMed is pursuing four key strategic growth drivers: (1) Expanding the Global Sleep Apnea Funnel: With an estimated 936 million people worldwide suffering from sleep apnea and over 80% remaining undiagnosed, ResMed is partnering with consumer health leaders (Apple, Samsung) and sleep testing innovators (NightOwl) to streamline home sleep apnea testing; (2) Accelerating AirSense 11 Global Conversion: Completing the worldwide rollout of the AirSense 11 platform, featuring enhanced digital coaching and touchscreens, driving device upgrades; (3) Expanding Post-Acute SaaS Platform: Cross-selling Brightree and MatrixCare practice management software to nursing homes, home health agencies, and outpatient providers; and (4) Harnessing Generative AI for Therapy Adherence: Deploying AI algorithms within the myAir patient app to provide customized behavioral nudges, troubleshooting air leaks and mask fit to maximize nightly compliance.
How ResMed Makes Money: FAQ
What are the primary revenue streams for ResMed?
ResMed generates consolidated revenue through multi-faceted operational channels, including core product and service fees, interest margin spreads, long-term subscription or administrative contracts, and ancillary value-added services, producing $4.68B in annual turnover.
How does ResMed achieve operating leverage?
ResMed achieves exceptional operating leverage by deploying proprietary automated digital infrastructure that handles rising transaction volumes without proportionate increases in workforce headcount or administrative overhead.
Who are ResMed's target customer segments?
ResMed serves a broad spectrum of commercial and consumer clients, spanning individual retail households, small-to-medium businesses, large multinational corporations, and institutional investment entities requiring mission-critical solutions.
How does ResMed manage operational and credit risk?
ResMed enforces strict risk management governance, automated real-time compliance surveillance, conservative capital adequacy reserves, and diversified exposure limits across all business units.
Related Monetization Mechanics
Compare revenue streams, unit economics, and business models
Explore ResMed
Core profile pages, founders and related research hubs for this company.